Document Detail


Prenatal therapy for fetal growth restriction.
MedLine Citation:
PMID:  16721109     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The choice of therapy for fetal growth restriction (FGR) depends on the nature of the insult that led to the development of FGR. Many etiologic factors are either not amenable to therapy or fetal growth has not been improved by treatments that benefit the mother. Many therapeutic approaches have been used to improve fetal condition. None of the approaches have been of value in a consistent manner. We present the numerous approaches, and their rationale for their use, that have been tried to treat the growth impaired fetus. The evidence from the randomized clinical trials is summarized and their conclusions given.
Authors:
Reinaldo Figueroa; Dev Maulik
Related Documents :
18633329 - Drinking water disinfection by-product exposure and duration of gestation.
23548219 - Effect of intraumbilical vein oxytocin injection on third stage of labor.
23168759 - Epidemiology, natural history, progression, and postnatal outcome of severe fetal ventr...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical obstetrics and gynecology     Volume:  49     ISSN:  0009-9201     ISO Abbreviation:  Clin Obstet Gynecol     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-05-24     Completed Date:  2008-01-16     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0070014     Medline TA:  Clin Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  308-19     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Winthrop University Hospital, Mineola, New York, USA. rfigueroa@notes.cc.sunysb.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Agonists / administration & dosage
Aspirin / administration & dosage
Bed Rest
Calcium Channel Blockers / administration & dosage
Calcium, Dietary / administration & dosage
Diet, Sodium-Restricted
Dietary Supplements
Female
Fetal Growth Retardation / drug therapy,  prevention & control,  therapy*
Fish Oils / administration & dosage
Folic Acid / administration & dosage
Humans
Iron Compounds / administration & dosage
Lower Body Negative Pressure
Magnesium Compounds / administration & dosage
Meta-Analysis as Topic
Nitric Oxide Donors / administration & dosage
Nutritional Support
Oxygen Inhalation Therapy
Plasma Substitutes / administration & dosage
Pregnancy
Pregnancy Outcome
Randomized Controlled Trials as Topic
Vitamins / administration & dosage
Zinc Compounds / administration & dosage
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Calcium Channel Blockers; 0/Calcium, Dietary; 0/Fish Oils; 0/Iron Compounds; 0/Magnesium Compounds; 0/Nitric Oxide Donors; 0/Plasma Substitutes; 0/Vitamins; 0/Zinc Compounds; 50-78-2/Aspirin; 59-30-3/Folic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sonographic diagnosis of fetal growth restriction.
Next Document:  Management of fetal growth restriction: an evidence-based approach.